DocuSign (DOCU) is trading lower as the market digests renewed analyst skepticism following recent price-target cuts and rating downgrades that have weighed on sentiment for weeks. The latest catalyst in the analyst cycle is a May 5 note highlighting a lower target from BTIG Research, keeping pressure on the stock as investors debate how much growth is left in the core e-signature business versus newer Intelligent Agreement Management offerings.

Recent analyst actions have leaned cautious, with targets reset sharply lower and multiple firms emphasizing valuation discipline and muted top-line growth expectations. Citigroup’s April downgrade to Neutral and large target reduction became a key reference point for bears, and follow-on target cuts from other firms have reinforced the narrative that DocuSign needs clearer evidence of re-accelerating demand to earn a higher multiple.

The next near-term focus is the company’s upcoming earnings event timeline and any incremental signals on billings, customer retention, and IAM adoption. Traders are also watching whether buybacks meaningfully tighten supply and stabilize the tape, but the stock’s direction near-term is likely to hinge on whether management can show improving growth metrics versus the lowered bar implied by recent target resets.